$MRZM
Marizyme Inc Stock $mrzm

$mrzm Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224032184 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue			$184.7K
YoY Change			198.89%
Cost Of Revenue			$49.61K
YoY Change			349.78%
Gross Profit			$135.1K
YoY Change			166.1%
Gross Profit Margin			73.15%
Selling, General & Admin		$1.156M	$3.875M
YoY Change		-70.18%	26.2%
% of Gross Profit			2867.92%
Research & Development		$312.3K	$691.4K
YoY Change		-54.83%	-49.59%
% of Gross Profit			511.66%
Depreciation & Amortization		$121.3K	$210.3K
YoY Change		-42.33%	-0.03%
% of Gross Profit			155.62%
Operating Expenses		$1.589M	$4.939M
YoY Change		-67.82%	5.91%
Operating Profit		-$1.589M	-$4.804M
YoY Change		-66.92%	4.39%
Interest Expense		-$3.438M	-$13.42M
YoY Change		-74.39%	2431.76%
% of Operating Profit
Other Income/Expense, Net		-$2.483M	-$15.77M
YoY Change		-84.26%	579.19%
Pretax Income		-$4.073M	-$20.58M
YoY Change		-80.21%	197.18%
Income Tax
% Of Pretax Income
Net Earnings		-$4.073M	-$20.58M
YoY Change		-80.21%	197.18%
Net Earnings / Revenue			-11138.09%
Basic Earnings Per Share		-$0.03	-$0.48
Diluted Earnings Per Share		-$0.03	-$0.48
COMMON SHARES
Basic Shares Outstanding	131.8M shares	131.8M shares	43.42M shares
Diluted Shares Outstanding		131.8M shares	43.19M shares

Balance Sheet

Concept	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.220K	$205.2K
YoY Change	-97.46%	-89.96%
Cash & Equivalents	$5.222K	$205.2K
Short-Term Investments
Other Short-Term Assets	$854.2K	$606.4K
YoY Change	40.87%	157.6%
Inventory	$26.87K	$139.7K
Prepaid Expenses	$854.1K	$606.3K
Receivables		$72.98K
Other Receivables	$35.85K	$34.30K
Total Short-Term Assets	$922.1K	$1.059M
YoY Change	-12.89%	-59.51%
LONG-TERM ASSETS
Property, Plant & Equipment		$12.50K
YoY Change		-1.43%
Goodwill	$5.416M	$7.191M
YoY Change	-24.68%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$150.5K	$170.8K
YoY Change	-11.91%	-53.71%
Total Long-Term Assets	$20.61M	$35.92M
YoY Change	-42.62%	-41.76%
TOTAL ASSETS
Total Short-Term Assets	$922.1K	$1.059M
Total Long-Term Assets	$20.61M	$35.92M
Total Assets	$21.53M	$36.98M
YoY Change	-41.77%	-42.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.269M	$2.038M
YoY Change	60.41%	230.29%
Accrued Expenses	$439.5K	$428.8K
YoY Change	2.5%	2.5%
Deferred Revenue
YoY Change
Short-Term Debt	$990.6K	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$18.56M	$12.75M
YoY Change	45.6%	5181.86%
Total Short-Term Liabilities	$23.55M	$20.82M
YoY Change	13.11%	1287.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$307.4K
YoY Change	-100.0%	-63.53%
Other Long-Term Liabilities	$7.363M	$8.583M
YoY Change	-14.21%	-58.35%
Total Long-Term Liabilities	$7.363M	$8.890M
YoY Change	-17.18%	-58.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.55M	$20.82M
Total Long-Term Liabilities	$7.363M	$8.890M
Total Liabilities	$30.91M	$29.71M
YoY Change	4.05%	29.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$161.6M	-$109.1M
YoY Change	48.13%	79.26%
Common Stock	$131.8K	$45.37K
YoY Change	190.51%	11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.380M	$7.270M
YoY Change
Total Liabilities & Shareholders Equity	$21.53M	$36.98M
YoY Change	-41.77%	-42.49%

Cashflow Statement

Concept	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$4.073M	-$20.58M
YoY Change	-80.21%	197.18%
Depreciation, Depletion And Amortization	$121.3K	$210.3K
YoY Change	-42.33%	-0.03%
Cash From Operating Activities	-$732.9K	-$1.198M
YoY Change	-38.81%	-56.31%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	732.0K	1.073M
YoY Change	-31.8%	-33.5%
NET CHANGE
Cash From Operating Activities	-732.9K	-1.198M
Cash From Investing Activities
Cash From Financing Activities	732.0K	1.073M
Net Change In Cash	-930.0	-124.6K
YoY Change	-99.25%	-88.96%
FREE CASH FLOW
Cash From Operating Activities	-$732.9K	-$1.198M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	210966	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	153600	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7269656	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001413754
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53223
	dei	Entity Registrant Name EntityRegistrantName	MARIZYME, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-5464863
	dei	Entity Address Address Line1 EntityAddressAddressLine1	555 Heritage Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 205
	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33458
	dei	City Area Code CityAreaCode	(561)
	dei	Local Phone Number LocalPhoneNumber	935-9955
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	us-gaap	Cash Cash	5222	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	854148	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	26869	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	899411	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14146575	usd
CY2024Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	120500	usd
CY2024Q2	us-gaap	Deposit Assets DepositAssets	30000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	5416000	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	20612486	usd
CY2024Q2	us-gaap	Assets Assets	21534573	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3269250	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1541627	usd
CY2024Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	17022717	usd
CY2024Q2	MRZM	Convertible Debt Original Issue Discount Current ConvertibleDebtOriginalIssueDiscountCurrent	990636	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	439508	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	23551638	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	459903	usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	131793088	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023Q4	MRZM	Agreement Obligation Noncurrent AgreementObligationNoncurrent		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2024Q2	us-gaap	Gross Profit GrossProfit		usd
CY2024Q2	us-gaap	Royalty Expense RoyaltyExpense		usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q2	MRZM	Borrowing Costs BorrowingCosts		usd
	MRZM	Borrowing Costs BorrowingCosts		usd
CY2024Q2	MRZM	Loss On Issuance Of Debt LossOnIssuanceOfDebt		usd
	MRZM	Loss On Issuance Of Debt LossOnIssuanceOfDebt		usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	MRZM	Loss On Issuance Of Debt LossOnIssuanceOfDebt		usd
	MRZM	Shares Issued As Part Of Confidential Settlement Agreement SharesIssuedAsPartOfConfidentialSettlementAgreement		usd
	MRZM	Shares Issued For Services SharesIssuedForServices		usd
	MRZM	Warrants Issued As Part Of Promissory Note Agreement WarrantsIssuedAsPartOfPromissoryNoteAgreement		usd
	MRZM	Borrowing Costs BorrowingCosts		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities		usd
	MRZM	Debt Discount Issued In Connection With Warrants Modification DebtDiscountIssuedInConnectionWithWarrantsModification		usd
	MRZM	Derivative Liabilities And Debt Discount Issued In Connection With Convertible Notes DerivativeLiabilitiesAndDebtDiscountIssuedInConnectionWithConvertibleNotes		usd
	MRZM	Warrants And Debt Discount Issued In Connection With Convertible Notes WarrantsAndDebtDiscountIssuedInConnectionWithConvertibleNotes		usd
	MRZM	Settlement Of Notes Payable With Convertible Notes SettlementOfNotesPayableWithConvertibleNotes		usd
	MRZM	Warrants Cancelled In Debt Extinguishment WarrantsCancelledInDebtExtinguishment		usd
	MRZM	Shares Issued On Conversion Of Convertible Notes SharesIssuedOnConversionOfConvertibleNotes		usd
CY2023Q4	us-gaap	Notes Payable NotesPayable		usd
CY2023Q2	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold		usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold		usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	131793088	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2023Q4	us-gaap	Cash Cash	148465	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60284	usd
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	35848	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	35797	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	699377	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	24855	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	922087	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	968778	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12500	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1101211	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14364129	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	122457	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	30000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5416000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	21046297	usd
CY2023Q4	us-gaap	Assets Assets	22015075	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2322064	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	633692	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	14288335	usd
CY2023Q4	MRZM	Convertible Debt Original Issue Discount Current ConvertibleDebtOriginalIssueDiscountCurrent	2694256	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434082	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20602582	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	667129	usd
CY2024Q2	MRZM	Agreement Obligation Noncurrent AgreementObligationNoncurrent	1000000	usd
CY2024Q2	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	5903000	usd
CY2023Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	5406000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7362903	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6073129	usd
CY2024Q2	us-gaap	Liabilities Liabilities	30914541	usd
CY2023Q4	us-gaap	Liabilities Liabilities	26675711	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	131793088	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	131793088	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	131793088	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	131792	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	131792	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	152123457	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	146543921	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161635217	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151336349	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-9379968	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4660636	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21534573	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22015075	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184739	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32855	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	313713	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	49611	usd
	us-gaap	Cost Of Revenue CostOfRevenue	9647	usd
	us-gaap	Cost Of Revenue CostOfRevenue	88886	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	135128	usd
	us-gaap	Gross Profit GrossProfit	23208	usd
	us-gaap	Gross Profit GrossProfit	224827	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	338676	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	511844	usd
	us-gaap	Professional Fees ProfessionalFees	602772	usd
	us-gaap	Professional Fees ProfessionalFees	896650	usd
CY2024Q2	us-gaap	Salaries And Wages SalariesAndWages	355525	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	335004	usd
	us-gaap	Salaries And Wages SalariesAndWages	665684	usd
	us-gaap	Salaries And Wages SalariesAndWages	601972	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	312333	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	691393	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	634200	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1297390	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	41588	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	160762	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	95852	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	371728	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	121277	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	210293	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	230054	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	420631	usd
CY2023Q2	us-gaap	Royalty Expense RoyaltyExpense	162065	usd
	us-gaap	Royalty Expense RoyaltyExpense	1957	usd
	us-gaap	Royalty Expense RoyaltyExpense	198248	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	419961	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2867749	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	754141	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3375073	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1589360	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	4939110	usd
	us-gaap	Operating Expenses OperatingExpenses	2984660	usd
	us-gaap	Operating Expenses OperatingExpenses	7161692	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1589360	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4803982	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2961452	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6936865	usd
CY2024Q2	MRZM	Interest And Accretion Expenses Other InterestAndAccretionExpensesOther	2938416	usd
CY2023Q2	MRZM	Interest And Accretion Expenses Other InterestAndAccretionExpensesOther	13424169	usd
	MRZM	Interest And Accretion Expenses Other InterestAndAccretionExpensesOther	7100246	usd
	MRZM	Interest And Accretion Expenses Other InterestAndAccretionExpensesOther	15121870	usd
CY2024Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	200000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	200000	usd
CY2024Q2	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	88000	usd
CY2023Q2	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	714000	usd
	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	-497000	usd
	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	1990000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	667200	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-684682	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	559830	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-684682	usd
CY2024Q2	MRZM	Borrowing Costs BorrowingCosts	500000	usd
	MRZM	Borrowing Costs BorrowingCosts	500000	usd
CY2023Q2	MRZM	Loss On Issuance Of Debt LossOnIssuanceOfDebt	2377569	usd
	MRZM	Loss On Issuance Of Debt LossOnIssuanceOfDebt	2377569	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2483216	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15772420	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7337416	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16194121	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4072576	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-20576402	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10298868	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23130986	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131793088	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131793088	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43187439	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43187439	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131793088	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131793088	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41979194	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41979194	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17421985	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2554584	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	15231967	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	160762	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	223486	usd
CY2023Q2	MRZM	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	265216	usd
CY2023Q2	MRZM	Adjustments To Additional Paid In Capital Issuance Of Warrants On Debt Extinguishment AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsOnDebtExtinguishment	19058426	usd
CY2023Q2	MRZM	Adjustments To Additional Paid In Capital Issuance Of Warrants On Promissory Note AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsOnPromissoryNote	1333128	usd
CY2023Q2	MRZM	Stock Issued During Period Warrants Cancelled In Debt Extinguishment StockIssuedDuringPeriodWarrantsCancelledInDebtExtinguishment	-8426927	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-20576402	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4660636	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54264	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6226292	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-10832664	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-10832664	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	41588	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5483684	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4072576	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-9379968	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-9379968	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10298868	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23130986	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	230054	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	420631	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	201800	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	95852	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	371728	usd
	MRZM	Interest And Accretion Expenses InterestAndAccretionExpenses	7100246	usd
	MRZM	Interest And Accretion Expenses InterestAndAccretionExpenses	15121870	usd
	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	-497000	usd
	MRZM	Gain Loss On Fair Value Of Contingent Liabilities GainLossOnFairValueOfContingentLiabilities	1990000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	559830	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-684682	usd
	MRZM	Loss On Issuance Of Debt LossOnIssuanceOfDebt	2377569	usd
	MRZM	Shares Issued As Part Of Confidential Settlement Agreement SharesIssuedAsPartOfConfidentialSettlementAgreement	153600	usd
	MRZM	Shares Issued For Services SharesIssuedForServices	138000	usd
	MRZM	Warrants Issued As Part Of Promissory Note Agreement WarrantsIssuedAsPartOfPromissoryNoteAgreement	1333128	usd
	MRZM	Borrowing Costs BorrowingCosts	500000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-60233	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	4171	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	154771	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-519414	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2014	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-75843	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	932496	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1657909	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	57747	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	143351	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-201800	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-190581	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1541855	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2318013	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	870000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	265216	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1040000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1000000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	141388	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	122842	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	500000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1398612	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2012374	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-143243	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-305639	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	148465	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	510865	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5222	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	205226	usd
	MRZM	Debt Discount Issued In Connection With Warrants Modification DebtDiscountIssuedInConnectionWithWarrantsModification	5344229	usd
	MRZM	Derivative Liabilities And Debt Discount Issued In Connection With Convertible Notes DerivativeLiabilitiesAndDebtDiscountIssuedInConnectionWithConvertibleNotes	5461702	usd
	MRZM	Warrants And Debt Discount Issued In Connection With Convertible Notes WarrantsAndDebtDiscountIssuedInConnectionWithConvertibleNotes	19058426	usd
	MRZM	Settlement Of Notes Payable With Convertible Notes SettlementOfNotesPayableWithConvertibleNotes	2064133	usd
	MRZM	Warrants Cancelled In Debt Extinguishment WarrantsCancelledInDebtExtinguishment	8426927	usd
	MRZM	Shares Issued On Conversion Of Convertible Notes SharesIssuedOnConversionOfConvertibleNotes	84140	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161635217	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151336349	usd
CY2024Q2	MRZM	Working Capital WorkingCapital	-22629551	usd
CY2023Q4	MRZM	Working Capital WorkingCapital	-19633804	usd
CY2024Q2	us-gaap	Cash Cash	5222	usd
CY2023Q4	us-gaap	Cash Cash	148465	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zVwDpkrDsmV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zVpQcaz0Gsn8">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make use of certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenue and expenses during the reported periods. The Company bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Significant estimates are related to the recoverability of long-term assets including intangible assets and goodwill, amortization expense, valuation of warrants, stock-based compensation, and contingent liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	MRZM	Midrange Average Estimated Interest Rate MidrangeAverageEstimatedInterestRate	0.206	pure
CY2024Q2	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	10000	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	637000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3995000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3358000	usd
CY2020Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	five-and-a-half-year lease agreement
CY2020Q4	us-gaap	Area Of Land AreaOfLand	10300	sqft
CY2024Q2	us-gaap	Payments For Rent PaymentsForRent	63885	usd
	us-gaap	Payments For Rent PaymentsForRent	161058	usd
CY2023Q2	us-gaap	Payments For Rent PaymentsForRent	37674	usd
	us-gaap	Payments For Rent PaymentsForRent	192502	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	899411	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1101211	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	439508	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434082	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	459903	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	667129	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	899411	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1101211	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	217041	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	444934	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	266034	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	928009	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	28598	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	899411	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15850745	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1704170	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14146575	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29142745	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2308896	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	12469720	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14364129	usd
CY2024Q2	us-gaap	Goodwill Goodwill	5416000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5416000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27675020	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	12469720	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	841171	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14364129	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	217554	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14146575	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	755000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	4260594	shares
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6692765	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	4180071	shares
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6500743	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	684682	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	4207828	shares
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	344959	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	9340774	usd
CY2024Q2	MRZM	Interest And Accretion Expense InterestAndAccretionExpense	1342178	usd
	MRZM	Interest And Accretion Expense InterestAndAccretionExpense	3433668	usd
CY2023Q2	MRZM	Interest And Accretion Expense InterestAndAccretionExpense	5730714	usd
	MRZM	Interest And Accretion Expense InterestAndAccretionExpense	7286891	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4075749	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5483684	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5344229	usd
CY2024Q2	MRZM	Debt Accretion Expenses DebtAccretionExpenses	1566561	usd
	MRZM	Debt Accretion Expenses DebtAccretionExpenses	3640609	usd
CY2023Q2	MRZM	Debt Accretion Expenses DebtAccretionExpenses	150086	usd
	MRZM	Debt Accretion Expenses DebtAccretionExpenses	150086	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	131793088	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	131793088	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	131793088	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	131793088	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3925943	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.33
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y21D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3925943	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.33
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y21D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	211667	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1095000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.01
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2619276	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.44
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M13D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2519276	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M25D
CY2024Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	0	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	0	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5000000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5483684	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41588	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	95852	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	160762	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	371728	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-032184-index-headers.html	Edgar Link	pending
0001493152-24-032184-index.html	Edgar Link	pending
0001493152-24-032184.txt	Edgar Link	pending
0001493152-24-032184-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mrzm-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
mrzm-20240630_cal.xml	Edgar Link	unprocessable
mrzm-20240630_def.xml	Edgar Link	unprocessable
mrzm-20240630_lab.xml	Edgar Link	unprocessable
mrzm-20240630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v318342_ex3-1x1x2x1.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRZM
Marizyme Inc Stock $mrzm

2024 Q3 Form 10-Q Financial Statement

#000149315224032184 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRZM Marizyme Inc Stock $mrzm

2024 Q3 Form 10-Q Financial Statement

#000149315224032184 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRZM
Marizyme Inc Stock $mrzm